Sight Sciences Inc SGHT released the six-month SAHARA randomized controlled trial comparing interventional eyelid procedures enabled by TearCare Technology to Restasis for dry eye disease. TearCare is ...
You may qualify for free Restasis through the drug’s manufacturer, myAbbVie Assist. That said, you won’t use your Medicare coverage. Restasis (cyclosporine), a brand-name eye drop for chronic dry eyes ...
Patients treated with a single interventional eyelid procedure enabled by TearCare® technology after receiving Restasis® for the first six months of the trial realized clinically meaningful ...
Yes, people with Medicare Part D who use Restasis may be eligible for a patient assistance program called myAbbVie Assist. This article discusses whether Medicare covers Restasis, Medicare ...
PITTSBURGH, Feb. 3, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that its subsidiary, Mylan Pharmaceuticals Inc., has received approval from the U.S. Food and Drug Administration ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Preeya K. Gupta, MD, discusses a clinical ...
Restasis (cyclosporine ophthalmic emulsion) is a prescription drug that’s used to treat dry eye syndrome. The drug comes as an emulsion (oily liquid). You usually apply 1 drop into each affected eye ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback